Iterum Therapeutics plc - Ordinary Share

Share · IE000TTOOBX0 · ITRM (XNAS)

No Price

28.01.2026 18:05

Current Prices from Iterum Therapeutics plc - Ordinary Share

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	ITRM	USD	28.01.2026 18:05	0,33 USD	-0,02 USD -4,70 %

Company Profile for Iterum Therapeutics plc - Ordinary Share Share

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.

AI Analysis of Iterum Therapeutics plc - Ordinary Share

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of Iterum Therapeutics plc - Ordinary Share

No AI threads available for this company yet.

Company Data

Name Iterum Therapeutics plc - Ordinary Share

Company Iterum Therapeutics plc

Symbol ITRM

Website https://www.iterumtx.com

Primary Exchange

NASDAQ

ISIN IE000TTOOBX0

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Corey N. Fishman

Market Capitalization 18 Mio

Country Ireland

Currency USD

Employees 0,0 T

Address Fitzwilliam Court, 2 Dublin

IPO Date 2018-05-25

Ticker Symbols

Name	Symbol
NASDAQ	ITRM

More Shares

Investors who hold Iterum Therapeutics plc - Ordinary Share also have the following shares in their portfolio:

ALLENA PHARMACEUTICALS INC Share

SPANIEN 17-27 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog